EU/3/16/1764

Table of contents

About

On 14 October 2016, orphan designation (EU/3/16/1764) was granted by the European Commission to ProActina, Greece, for tetrofosmin for the diagnosis of glioma.

Key facts

Active substance
Tetrofosmin
Disease / condition
Diagnosis of glioma
Date of first decision
20/09/2016
Outcome
Positive
EU designation number
EU/3/16/1764

Sponsor's contact details

ProActina
Greece

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating